(Reported by 365 Medical News) Recently, at the invitation of Professor Bin Liu, Professor Andreas Baumbach from the Bristol Heart Institute in the UK, Professor Franz X. Kleber from Klinikum Potsdam Teaching Hospital in Germany, Professor Dominick J. Angiolillo from the University of Florida College of Medicine Jacksonville in the USA, and Professor Francesco Prati from the University of Catania in Rome, Italy, among other international experts, visited the Department of Cardiology at The Second Norman Bethune Hospital of Jilin University. They held discussions and exchanged ideas with Professor Bin Liu, Director of the department, and his team.
Professor Bin Liu introduced to the visiting international experts that the Department of Cardiology at The Second Norman Bethune Hospital of Jilin University is a national key clinical specialty designated by the Ministry of Health and is recognized as the "Jilin Provincial Interventional Cardiology Center" by the Jilin Provincial Health Department. The department pioneered comprehensive cardiac interventional techniques in Jilin Province and has extensive clinical experience in treating critical and complex cardiovascular diseases, particularly accumulating rich experience in areas such as CTO and drug-coated balloons. As the leading department in the field of interventional cardiology in Jilin Province, Professor Liu also discussed possibilities and forms of international research collaboration with the experts. The visiting overseas experts introduced their respective research fields and specialized directions, exchanged opinions on how to carry out cooperation and communication, and during their visit, delivered academic lectures and toured the inpatient wards and operating rooms of the Department of Cardiology at The Second Norman Bethune Hospital of Jilin University.
Professor Andreas Baumbach and Professor Bin Liu exchanged insights on interventional techniques.
Professor Andreas Baumbach delivered a speech.
Professor Bin Liu presented the published book to Professor Andreas Baumbach.
Professor Andreas Baumbach took a group photo with Professor Bin Liu's team.
On March 15, Professor Andreas Baumbach from the Bristol Heart Institute visited and engaged in academic exchanges at the hospital. It is understood that Dr. Andreas Baumbach serves as a Consultant Cardiologist at the Bristol Heart Institute and is also an Honorary Professor of Interventional Cardiology at the University of Bristol. He previously worked and studied at the University of Tübingen in Germany.
Dr. Andreas Baumbach is currently involved in clinical research on acute coronary syndromes and participates in the evaluation of the latest technologies in the field of interventional cardiology. He was the principal leader in the field of interventional cardiology for the NIHR Biomedical Research Unit at the Bristol Heart Institute in 2012.
Additionally, Dr. Andreas Baumbach is a member of the Council of the British Cardiovascular Intervention Society (BCIS) and has served as the Chair of the Training and Education Committee since 2011. As a board member of the European Association of Percutaneous Cardiovascular Interventions (EAPCI), he was elected Secretary of EAPCI in 2014. Dr. Andreas Baumbach is also a member of the board and program committee of EuroPCR. Since 2008, EuroPCR has become the largest organization in the field of interventional cardiology.
Professor Franz X Kleber delivered a speech.
Professor Franz X Kleber and Professor Bin Liu took a photo together.
Professor Franz X Kleber and Professor Bin Liu took a photo together.
Professor Franz X Kleber and Professor Bin Liu took a photo together.
On March 16, Professor Franz X Kleber from Klinikum Potsdam Teaching Hospital in Germany visited the hospital for a tour and discussion. It is reported that Prof. Franz X Kleber serves as the Director of the Heart and Vascular Center at Klinikum Potsdam Teaching Hospital in Germany. He holds significant academic roles in several prestigious organizations, including the European Society of Cardiology (ESC), the International Society of Cardiology (ISC), the American Heart Association (AHA), the European Association of Percutaneous Cardiovascular Interventions (EAPCI), the German Cardiac Society, and the Italian Cardiac Society. Additionally, he is a member of the editorial boards of numerous European and American cardiology journals.
With over 40 years of experience in cardiovascular diseases, Prof. Kleber possesses extensive clinical expertise, particularly in the interventional diagnosis and treatment of coronary heart disease. He has developed unique academic insights into the clinical application of drug-coated balloons (DCB), leading and participating in the development and multiple revisions of the "German DCB Expert Consensus." He has also spearheaded and contributed to numerous international studies on DCB, publishing dozens of academic articles on the subject in internationally renowned journals. Over the years, he has made active contributions to the academic advancement of cardiovascular diseases and the promotion of new technologies in the interventional diagnosis and treatment of coronary heart disease.
Professor Dominick J. Angiolillo delivered a keynote report.
Professor Dominick J. Angiolillo took a group photo with Professor Bin Liu.
Professor Dominick J. Angiolillo took a group photo with Professor Bin Liu.
Professor Dominick J. Angiolillo took a group photo with Professor Bin Liu.
On March 16, Professor Dominick J. Angiolillo from the University of Florida College of Medicine Jacksonville delivered a report titled "Optimal Antithrombotic Therapy for High-Risk ACS Patients Undergoing PCI: A Practical Perspective (and Personal Views)." Professor Angiolillo began by summarizing his approach to optimal antithrombotic therapy for stable CAD in one sentence—aspirin, clopidogrel, and UFH. He then provided a detailed interpretation of the optimal antithrombotic strategies for NSTEMI and STEMI based on clinical practical experience, large-scale clinical studies, and clinical guidelines.
It is reported that Dr. Angiolillo is a professor at the University of Florida College of Medicine Jacksonville. He is a cardiologist and interventional cardiologist at the University of Florida Health System, Director of the Cardiovascular Research Center, and Director of the Interventional Cardiology Research Program. His main research areas include interventional cardiology and acute coronary syndromes. Recognized internationally for his outstanding contributions to the field of thrombosis, he was awarded the European Society of Cardiology Outstanding Achievement Award in 2013 and was successfully selected as one of Thomson Reuters' World's Most Influential Scientists in 2014.
Professor Francesco Prati delivered a speech.
Professor Francesco Prati and Professor Bin Liu took a photo together.
Professor Bin Liu gave an introduction to Professor Francesco Prati.
Professor Francesco Prati took a group photo with Professor Bin Liu's team.
On March 16, Professor Francesco Prati from the University of Catania in Rome, Italy, engaged in in-depth discussions with Professor Bin Liu’s team at The Second Norman Bethune Hospital of Jilin University. Professor Francesco Prati had previously visited for academic exchanges with Professor Liu’s team in March 2015, during which a strong friendship was established, and they have maintained contact ever since.
Professor Francesco Prati serves as the Director of Interventional Cardiology at San Giovanni Hospital in Rome, Italy, a Professor at the Cardiovascular Center of the University of Catania, and the Director of the Rome Heart Research Center. He is a renowned scholar in the field of intravascular imaging evaluation, with profound expertise in the application of CTO (chronic total occlusion) techniques. He has led and participated in the development of the "Expert Consensus on Intravascular Imaging Evaluation." As the lead researcher of multiple European clinical studies, he has published over 150 internationally influential papers and several academic works.
With the extensive exchanges and deepening cooperation with overseas experts, the Cardiovascular Hospital of The Second Norman Bethune Hospital of Jilin University, under the leadership of Professor Bin Liu, is poised to achieve high-level, comprehensive development. It is gradually evolving into a comprehensive cardiovascular hospital that integrates prevention, diagnosis, treatment, scientific research, and training—equipped with international vision, innovative awareness, regional influence, and digital capabilities.
